GlassScriptPhysician profile
James G Marx
NPI 1922153907
$1,635.58
in general payments reported to CMS, 2019-2025
14 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $56.31 · 2021: $114 · 2022: $386 · 2023: $238 · 2024: $252 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $370.98 | 2019-2023 | Relistor |
| Biodelivery Sciences International, INC. | $198.33 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $174.69 | 2024-2025 | |
| Pfizer INC. | $141.55 | 2023-2024 | |
| Averitas Pharma INC. | $136.46 | 2023-2024 | Qutenza |
| Orexo US, INC. | $130.35 | 2022 | |
| Ibsa Pharma INC. | $125.00 | 2022 | |
| Collegium Pharmaceutical, INC. | $112.33 | 2019-2022 | |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Abbvie INC. | $69.08 | 2023 | |
| Eisai INC. | $39.63 | 2020 | |
| Impel Pharmaceuticals INC. | $22.53 | 2022 | |
| Forte Bio-Pharma LLC | $16.68 | 2020 | |
| Sentynl Therapeutics, INC. | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Marx listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.